Skip to content
‹ Back to IndustriesHealthcare

Health and Life Sciences at the Edge: Privacy Frameworks in Health and Life Sciences

The American Journal of Medicine noted that healthcare organizations, or HCOs, require a framework that preserves privacy and supports the kind of data collaboration that will make tomorrow’s scientific and clinical advances possible while still supporting improved patient outcomes and experiences. Establishing this framework is challenging. Can AI solutions meet those privacy requirements for healthcare…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The American Journal of Medicine noted that healthcare organizations, or HCOs, require a framework that preserves privacy and supports the kind of data collaboration that will make tomorrow’s scientific and clinical advances possible while still supporting improved patient outcomes and experiences. Establishing this framework is challenging. Can AI solutions meet those privacy requirements for healthcare and life science applications? This is the question host Hilary Kennedy posed to BeeKeeperAI’s CEO Michael Blum, MD and Intel’s Health and Life Sciences General Manager, Chris Gough.

“Even large health organizations do not have the diversity, quality, or amount of data required to create high-quality, generalizable AI,” said Blum. “The solution is a federated framework that allows each data steward to ensure the privacy of their data by keeping it in their protected cloud, while validating and training AI across all of those stewards.”

Gough agreed, saying, “If you can reduce the friction to accessing large, diverse, high-quality data sets – and use those data sets as part of the AI training step – then the algorithms that result will be more accurate for multiple populations.”

“Healthcare AI is projected to be a $46 billion dollar market. When you turn that into human impact, there’s a tremendous opportunity to improve the quality of care and reduce the cost of care,” said Blum. “But the challenge we see over-and-over again is that the algorithms don’t generalize across populations. Their accuracy and performance fall off dramatically. We have to get rapid access to much broader and much more diverse data sets.”

“We really have a supply and demand problem in healthcare,” Gough added. “AI will help the industry better target the scarce resources it has, allowing organizations to be less reactive and more proactive and predictive.”

To learn more about Michael Blum, MD, and Chris Gough:

Connect with them on LinkedIn

Visit https://www.beekeeperai.com/

Read the “Privacy-Preserving Data-Collaboration Methods that Accelerate Healthcare Innovation” white paper: https://www.intel.com/content/www/us/en/healthcare-it/resources/confidential-computing-whitepaper.html

Subscribe to this channel on Apple Podcasts, Spotify, or Google Podcasts to hear more from the Intel Internet of Things Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Pharma rates its follow-through on diagnostic data 5.2 out of 10 in Diaceutics survey

Pharma rates its follow-through on diagnostic data 5.2 out of 10 in Diaceutics survey

In a Diaceutics survey of 125 US pharma leaders, respondents rated the significance of converting diagnosis into treatment to future commercial success at an average of 7.5 out of 10. They rated their organizations' effectiveness at turning diagnostic insights into coordinated action at just 5.2 out of 10. Separate Diaceutics lung cancer research found the largest gap now occurs at the point of treatment decision.

  • 01Pharma leaders rated their confidence in identifying eligible patients at 6.6 out of 10, their visibility across the patient journey at 5.4 and their effectiveness at turning diagnostic insights into coordinated action at 5.2. The low last score could point to the treatment decision, where Diaceutics' lung cancer research found the largest gap now occurs.
  • 02In US advanced non-small cell lung cancer, Diaceutics found overall patient loss virtually unchanged at 65.1% in 2023 versus 64.4% in 2019, while patient loss at the point of treatment decision rose from 29.2% to 43.3%. For operators, a flat headline rate could hide one step getting worse.
  • 03Senior leaders from several top 20 pharma companies argue diagnostic planning belongs early in development and commercialization, rather than as a testing and adoption fix after launch.

Nov 22, 2026

Frequent use of clinical AI tools rose to 34% in Elsevier's 2026 clinician survey

Elsevier's Clinician of the Future 2026 survey found 49% of clinicians use AI at work. Purpose-built clinical AI is gaining fast. Its frequent use rose from 22% in 2025 to 34% this year, yet 41% of nurses say their views are rarely or never sufficiently considered in important organizational decisions.

  • 01A sharper vendor question: which evidence base grounds the tool's answers, and can a clinician see that source at the moment of use? Transparency and authoritative data top clinicians' own list of what builds trust.

Nov 22, 2026

Zoom's stake in Medaica aims to bring the physical exam into video visits

Zoom Ventures made an undisclosed strategic investment in Medaica, whose FDA-cleared M1 telehealth stethoscope supports real-time remote heart and lung auscultation. Zoom already integrates with EHRs including Epic, Oracle Cerner Millennium and Athenahealth, but an investment is not an integration and no combined product has been announced. Cardiology follow-ups and care facilities are highlighted as likely early use cases.

  • 01Video gave telehealth the patient's face; an FDA-cleared remote stethoscope adds the heartbeat, and Zoom now has a financial stake in that second layer.
  • 02Today's cleared capability is real-time heart and lung auscultation; the wider mix of third-party devices, AI analysis and decision support is still in development.
  • 03For health systems with elderly or rural cardiology panels, the sharper vendor question is how exam findings reach the EHR record of the visit.

Nov 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512